35 Years of experimental research in transmyocardial revascularization: What have we learned?

Annals of Thoracic Surgery

Volumn 74, Issue 3, 2002, Pages 956-970

  Huikeshoven, Menno ^a   Beek, Johan F ^a   Van der Sloot, Jos A P ^a   Tukkie, Raymond ^a   Van der Meulen, Jan ^a   Van Gemert, Martin J C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; DENERVATION; ELECTRIC POTENTIAL; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTHESIS; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TECHNIQUE;

ANIMALS; HEART VENTRICLES; HUMANS; LASER SURGERY; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);

EID: 0036711638     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03547-0     Document Type: Review

References (112)

1. Transmyocardial revascularization: A new approach to myocardial revascularization
2. Revascularization of the heart by laser
3. Myocardial revascularization by laser: A clinical report
4. Transmyocardial puncture revascularization. A possible emergency adjunct to arterial implant surgery
5. Myocardial revascularization by transmyocardial acupuncture: A physiologic impossibility
6. Transmural channels can protect ischemic tissue. Assessment of long-term myocardial response to laser- and needle-made channels
7. Angiogenesis in transmyocardial laser revascularization - A nonspecifc response to injury
8. Percutaneous myocardial revascularization using a myocardial channeling device: First human experience using the AngioTrax system
9. The feasibility of using focused ultrasound for transmyocardial revascularization
10. Cryoapplication induces neovascularization: A novel approach to percutaneous myocardial revascularization
11. Transmyocardial revascularisation using temperature controlled HF energy creates reproducible intramyocardial channels
12. Radio frequency transmyocardial revascularization enhances angiogenesis and causes myocardial denervation in a canine model
13. Percutaneous myocardial revascularization with a newly developed high pressure saline-jet system: Evaluation of acute and chronic effects in porcine hearts
14. Percutaneous transmyocardial laser revascularisation for severe angina: The PACIFIC randomised trial
15. Transmyocardial laser revascularization combined with coronary artery bypass grafting: A multicenter, blinded, prospective, randomized, controlled trial
16. One-month histologic response of transmyocardial laser channels with molecular intervention
17. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization
18. Therapeutic angiogenesis induced by FGF-2 gene delivery combined with laser transmyocardial revascularization
19. Combined use of transmyocardial laser revascularisation with basic fibroblastic growth factor in chronically ischemic porcine hearts
20. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization
21. Experimental studies of laser myocardial revascularization in rats
22. Success of transmyocardial laser revascularization is determined by the amount and organization of scar tissue produced in response to initial injury: Results of ultraviolet laser treatment
23. Myocardial revascularization by laser-induced channels
24. Myocardial tissue ablation by single high-energy laser pulses for ELR and TMR
25. Acute and chronic effects of transmyocardial laser revascularization in the nonischemic pig myocardium by using three laser systems
26. 2 laser, the Holmium laser and the 308 nm excimer laser in view of transmyocardial revascularization
27. XeCl laser ablation of atherosclerotic aorta: Optical properties and energy pathways
28. Far-ultraviolet ablation of atherosclerotic lesions
29. The physical properties of tissue ablation with excimer lasers
30. 2 laser irradiation
31. Limits of radial time constants to approximate thermal response of tissue
32. The nature of the vascular communications between the coronary arteries and the chambers of the heart
33. Myocardial canalization: A new method of myocardial revascularization
34. Multiple transmyocardial puncture revascularization in refractory ventricular fibrillation due to myocardial ischemia
35. Experimental evaluation of direct transventricular revascularization
36. A histologic study of laser-induced transmyocardial channels
37. Alternative method of myocardial revascularization by laser: Experimental and clinical study
38. Long- and short-term effects of transmyocardial laser revascularization in acute myocardial ischemia
39. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization
40. Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: Results and comparisons to nonlased channels
41. Effect of transmyocardial laser revascularisation on chronic ischaemic hearts in sheep
42. Pathomorphological and histological analysis of the indirect revascularization method
43. Does blood flow through holmium:YAG transmyocardial laser channels?
44. 2 and holmium:YAG lasers
45. 2 laser
46. Evidence of vascular growth associated with laser treatment of normal canine myocardium
47. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization
48. Transmyocardial holmium-YAG laser channels in an animal model: A preliminary morphologic and histologic study
49. 2 laser
50. Transmyocardial laser revascularisation in acutely ischaemic myocardium
51. Angiogenesis in transmyocardial revascularization: Comparison of laser versus mechanical punctures
52. Myocardial scarring after transmyocardial laser revascularization: A potential mechanism of clinical improvement?
53. Transmyocardial laser revascularization fails to prevent left ventricular functional deterioration and aneurysm formation after acute myocardial infarction in sheep
54. Transmyocardial laser revascularisation in the acute ischaemic heart: No improvement of acute myocardial perfusion or prevention of myocardial infarction
55. 2-laser on rat myocardium
56. Histologic appearance of transmyocardial laser channels after 4 1/2 weeks
57. Transmyocardial laser revascularization. Histological features in human nonresponder myocardium
58. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization
59. Angiogenesis three months after clinical transmyocardial laser revascularization using an excimer laser
60. Transmyocardial revascularization: The fate of myocardial channels
61. Transmyocardial laser revascularization: A novel pathophysiological concept
62. Angiogenesis and growth factor expression in a model of transmyocardial revascularization
63. Angiogenic response induced by mechanical transmyocardial revascularization
64. Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated mice
65. Neovascularization occurs at the site of closed laser channels after transmyocardial laser revascularization
66. Up-regulation of vascular endothelial growth factor mRNA, and angiogenesis after transmyocardial laser revascularization
67. Transmyocardial laser revascularisation induced angiogenesis correlated with the expression of matrix metalloproteinases and platelet-derived endothelial cell growth factor
68. Evidence of angiogenesis in regions treated with transmyocardial laser revascularization
69. Angiogenesis. A possible mechanism underlying the clinical benefits of transmyocardial laser revascularization
70. Are there vascular density gradients along myocardial laser channels?
71. Does laser injury induce a different neovascularisation pattern from mechanical or ischaemic injuries?
72. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia
73. 2, and excimer lasers
74. Improved neoangiogenesis in transmyocardial laser revascularization combined with angiogenic adjunct in a pig model
75. Transmural channels as a source of blood flow to ischemic myocardium? Insights from the reptilian heart
76. 2 laser-induced intramyocardial revascularisation
77. 2 laser "revascularization" of the myocardium
78. Transmyocardial laser-revascularization. Experimental studies on prolonged acute regional ischemia
79. Transmyocardial laser revascularization: Experimental studies in healthy porcine myocardium
80. Microperfusion enhancement after TMLR in chronically ischemic porcine hearts
81. Laser-mediated transmural myocardial channels do not salvage acutely ischemic myocardium
82. Blood flow capacity via direct acute myocardial revascularization
83. Transmyocardial laser revascularization dose response: Enhanced perfusion in a porcine ischemia model as a function of channel density
84. Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium
85. Excimer versus carbon dioxide transmyocardial laser revascularization: Effects on regional left ventricular function and perfusion
86. Large variability in results may limit utility of thallium scans to detect improved blood flow in response to TMR or angiogenic therapies
87. Neurophysiological aspects of angina pectoris
88. Phenol topically applied to canine left ventricular epicardium interrupts sympathetic but not vagal afferents
89. Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk
90. Spinal cord stimulation in chronic intractable angina pectoris: A randomized, controlled efficacy study
91. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris
92. Transmyocardial laser treatment denervates canine myocardium
93. Distribution of left-ventricular sympathetic afferents demonstrated by reflex responses to transmural myocardial ischemia and to intracoronary and epicardial bradykinin
94. Transmyocardial laser revascularization does not denervate the canine heart
95. Transmyocardial laser revascularization remodels the intrinsic cardiac nervous system in a chronic setting
96. Nontransmural laser treatment incompletely denervates canine myocardium
97. Transmyocardial revascularization ameliorates ischemia by cardiac denervation and not by angiogenesis: New insights using contrast echocardiography
98. Denervation is not the long-term mechanism of action of transmyocardial laser revascularization
99. Transmyocardial laser revascularization (TMLR) and reflexes mediated by left ventricular (LV) receptors with sympathetic afferent (SA) fibers
100. Cardiac sympathetic denervation after transmyocardial laser revascularization
101. 2 laser
102. Left ventricular functional improvement after transmyocardial laser revascularization
103. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina
104. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial
105. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
106. Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial
107. 2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial